Estimate Recalculated Nov 1, 2024 10:26AM EST
Maged Shenouda does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RELMADA THERAPEUTICS, INC., AzurRx BioPharma, Inc., and Protea Biosciences Group, Inc..
Maged Shenouda's CIK is 0001658369
2021 was Maged Shenouda's most active year for acquiring shares with 11 total transactions. Maged Shenouda's most active month to acquire stocks was the month of November. 2021 was Maged Shenouda's most active year for disposing of shares, totalling 25 transactions. Maged Shenouda's most active month to dispose stocks was the month of January. 2019 saw Maged Shenouda paying a total of $6,338,894.00 for 620,978 shares, this is the most they've acquired in one year. In 2021 Maged Shenouda cashed out on 72,000 shares for a total of $1,257,011.72, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!